🎉We are thrilled to announce that ANKASCIN 568-R has been recognized as a finalist for the Healthy Aging Ingredient of the Year at the Nutraingredients Awards 2023. It is a cutting-edge ingredient that has been clinically proven to support blood glucose management, cardiovascular health, memory, cognitive health, and healthy aging. The uniqueness of ANKASCIN 568-R is that it contains high levels of Monascin and Ankaflavin, two active compounds that address the root cause of aging-related factors like advanced glycation end products, inflammatory cytokines, and reactive oxygen species via PPARγ/Nrf2 pathways. We are honored to be recognized for our commitment to innovation and excellence in the field of health and wellness. With growing public interest in anti-aging nutritional solutions, ANKASCIN 568-R fills a gap in the healthy aging supplement market.💪 Congratulations to all the finalists, and we look forward to continuing to drive innovation in the industry! Want to know more about ANKASCIN 568-R? contact us: globalservice@sunway.cc or call us at +886-2-2792-9568. #NutraingredientsAwards #HealthyAging #Innovation #ANKASCIN568R #Monascin #Ankaflavin #HealthAndWellness   Disclaimer: This communication is only intended for business-to-business. Nothing on this page is meant to be perceived as an approved claim by regulatory authorities.

🌟 Exciting News! #XYMOGEN Red Yeast Rice has been recognized as a finalist for the Nutraingredients USA Awards 2024: Botanical Product of the Year! 🌟 This marks our third consecutive nomination! #ANKASCIN568R is a clinically proven, cutting-edge ingredient featured in 130 SCI publications, supporting #5in1 health benefits. These benefits include activity against advanced glycation end products (AGEs), support for the body’s inflammatory response (cytokine balance), and improvements in blood sugar management, heart health, weight management, and cognitive health, all of which promote metabolic health and healthy aging. The uniqueness of this ingredient lies in its high levels of two active compounds, Monascin and Ankaflavin, and it is especially noteworthy for being free of #MonacolinK (statins). By activating #Nrf2 and #PPARs, it addresses core aging issues, including AGEs, inflammatory cytokines, and oxidative stress, while also enhancing lipid metabolism and insulin sensitivity. We deeply appreciate the relentless commitment of our R&D teams and the robust support from our customers. Join us in supporting XYMOGEN Red Yeast Rice as we aim for the top prize! 💪 For more info: https://www.nutraingredients-usa.com/Article/2024/05/22/NutraIngredients-USA-Awards-2024-finalists-announced #NutraingredientAsia #Finalist #antiaging #CardiovascularHealth #BloodSugarManagement #NIUawards23 #RedYeastRice

  We are honored to be awarded the Gold Award of 2022 Taiwan BIO Award! After three months of evaluation, the Taiwan Bio Industry Organization (TBIO) has selected 14 companies as the 2022 winners of the Taiwan BIO Awards by evaluating their operational performance, development potential, research and development capabilities, and social contribution. SunWay Biotech is honored to be listed as one of the winners awarded the Gold Award of 2022 Taiwan BIO Award! “SunWay Biotech Co., LTD.” was founded in 2007. As a leading world-class dietary supplement expert, SunWay Biotech aims to apply diverse and effective microorganisms, and develop efficient and unique fermentation processes, to provide high-quality products that ensure carefree health across the globe. “We hope to become the Intel in the dietary supplement industry, as the CPU of Intel which can be the core of the different computer brands. Our original, functional branded ingredients will play a vital role like the heart in the global dietary supplement company,” said John Pan, President of SunWay Biotech. Meanwhile, SunWay has performed many clinical trials, including regulating blood lipids, blood sugar, blood pressure, and Alzheimer’s disease, to demonstrate the benefits of our patented ingredients- ANKASCIN 568-R in Taiwan, Tientsin, and Los Angeles. Moreover, we also have two clinical trials in progress related to blood lipids regulation (HDL-C) and blood sugar modulation […]